Business & Economy · 9 views
Biogen Hits 52 - Week High , Alzheimer Drug Sales Jump
Biogen Inc. (NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, beating the consensus of $1.59.
Source finance.yahoo.com AI Summary Updated February 8, 2026
Business & Economy 
Story intelligence Beta
Freshness Stale Updated February 8, 2026
Confidence Limited Single-outlet story
Coverage Single outlet
Views 9 Community interest
Read time 1 min ~21 words
AI Summary
Biogen Inc. (NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, beating the consensus of $1.59. The Alzheimer
Read full article on FinanceAI summaries can be wrong sometimes—always verify important details using the source article.
SUPPORT HAPPENINGNOW · Independent AI News Intelligence
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Business & Economy
Continue reading recent Business & Economy coverage
- Ukrainian troops are pinning their hopes on a new top general after losing their star defense ministerContinue reading
- Investors are in the dark about the Fed’s decision this week — and that’s just how Warsh wants itContinue reading
- A 33-year-old nurse thought her bleeding was caused by hemorrhoids. She was diagnosed with stage 3 colon cancer.Continue reading